Trials / Completed
CompletedNCT01295021
The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.
A Non Interventional, Cross Sectional, Study on the Prevalence of Sympathetic Overactivity in Hypertensive Patients.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,514 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this NIS is to assess the prevalence of sympathetic overactivity in patients with newly diagnosed essential hypertension.
Detailed description
MC MD
Conditions
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2011-02-14
- Last updated
- 2013-06-10
Locations
97 sites across 1 country: India
Source: ClinicalTrials.gov record NCT01295021. Inclusion in this directory is not an endorsement.